Open AccessTHE PROBLEMS ASSOCIATED WITH SWITCHING BRAND-NAME ANTIEPILEPTIC DRUGS TO GENERICS: A FOCUS ON TOPAMAX: A REVIEW OF LITERATURE AND A CASE REPORT
Author(s) -
К. Ю. Мухин,
О. А. Пылаева,
М. Ю. Бобылова
Publication year - 2016
Publication title -
russkij žurnal detskoj nevrologii
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.139
H-Index - 2
eISSN - 2412-9178
pISSN - 2073-8803
DOI - 10.17650/2073-8803-2016-11-2-42-51
Subject(s) - interchangeability , tolerability , brand names , medicine , epilepsy , antiepileptic drug , intensive care medicine , advertising , pharmacology , business , psychiatry , computer science , adverse effect , programming language